Systemic monotherapy with acitretin for erythrodermic psoriasis: results of a retrospective study of 81 patients
Background: Erythrodermic psoriasis (EP) remains challenging to manage because it is rare and has complex complications. Although acitretin is recommended as an appropriate choice for EP, there is a lack of large-scale evidence. Objectives: This study aims to assess the efficacy and safety of acitre...
Saved in:
Main Authors: | Chenyang Yu (Author), Chao Wu (Author), Yuyan Yang (Author), Hongzhong Jin (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016) -
Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022) -
Updates on the Treatment of Erythrodermic Psoriasis
by: Lo Y, et al.
Published: (2021) -
Treatment of erythrodermic psoriasis with apremilast
by: Olivia A. Gioe, MD, et al.
Published: (2021) -
Efficacy of Acitretin Monotherapy on Basal Cell Carcinoma: A Case Report
by: Ping-Jiao Chen, et al.
Published: (2022)